Abstract
Human polymorphonuclear cells (PMN) and monocytes (MO) from four ovarian cancer patients and seventeen normal donors were in vitro pretreated with different concentrations (25, 50 and 100 IU, respectively) of rhGM-CSF. Phagocytosis and killing of PMN and MO as well as PMN polarization were evaluated in cancer patients before treatment (T0) and at the end of each chemotherapeutic cycle (T1, T2, T3 and T4, respectively) in comparison with normal donors. RhGM-CSF did not affect phagocytosis and killing of PMN and MO. On the other hand, this cytokine was per se endowed with the capacity to enhance PMN polarization in both cancer patients (at T2 interval) and normal donors.
References
Mar 1, 1992·Blood Reviews·A P RapoportJ F DiPersio
Jul 9, 1992·The New England Journal of Medicine·G J Lieschke, A W Burgess
Apr 1, 1992·Drugs·S M Grant, R C Heel
Jan 1, 1991·The Annals of Thoracic Surgery·J T WolfeS T Persellin
May 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M GianniG Bonadonna
Jan 1, 1989·Cancer Immunology, Immunotherapy : CII·G MasucciH Mellstedt
Nov 23, 1989·The New England Journal of Medicine·J E GroopmanD T Scadden
Feb 1, 1988·The British Journal of Ophthalmology·R S Rodriguez-SainsS L Bosniak
Dec 13, 1985·Science·K HuebnerJ C Gasson
Jun 1, 1987·The Journal of Clinical Investigation·C A Sieff
Jan 1, 1986·International Journal of Immunopharmacology·E JirilloS Antonaci
Aug 2, 1985·Journal of Immunological Methods·W S Haston, J M Shields
Sep 1, 1969·The American Journal of Medicine·G L Mandell, E W Hook
Jan 1, 1968·Scandinavian Journal of Clinical and Laboratory Investigation·C E Mogensen
Dec 14, 1984·Science·J C GassonD W Golde
Jan 1, 1994·European Journal of Haematology. Supplementum·J HarmenbergE Hellström-Lindberg
Mar 1, 1995·Immunopharmacology·L A BoberS K Narula
Mar 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·C WiltschkeC C Zielinski
May 1, 1993·Anti-cancer Drugs·T M Dexter, L J Fairbairn
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T C Jones
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K H Antman
Feb 1, 1996·Surgery·A D HillD Bouchier-Hayes
Apr 1, 1992·Drugs·Susan M Grant, Rennie C Heel
Citations
Apr 5, 2003·Immunopharmacology and Immunotoxicology·L PassantinoG Ranieri
Nov 17, 2006·Journal of Virology·Ioanna SkountzouSang-Moo Kang
Oct 15, 2010·Journal of Cellular Physiology·Tatsuya MorishimaToshio Heike
Jul 31, 2012·Journal of Radiation Research·Marcy B GraceMark H Whitnall
Jul 23, 2013·Annals of the Rheumatic Diseases·Konstantinos KambasIoannis Mitroulis
Oct 24, 2002·Blood·Frank El OuriaghliA John Barrett
Nov 9, 2019·Transplant International : Official Journal of the European Society for Organ Transplantation·Ana Luisa de Oliveira Bonnano AbibAna Cristina Breithaupt-Faloppa
Jan 13, 2000·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·O T PajuloJ A Viljanto